WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

WMT

82.12

-0.1%↓

164.99

-0.25%↓

COST

877.12

+0.15%↑

64.92

-0.64%↓

PEP

165.54

-0.48%↓

Home・Aktien・USANA Health Sciences Inc

USANA Health Sciences Inc

Geschlossen

37.22 0.87

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

36.75

Max

37.22

Schlüsselkennzahlen
By Trading Economics
Verkäufe	221M
EPS	0.87
Angestellte	1,800

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-6.14 downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	13M 911M
Vorheriger Eröffnungskurs	36.35
Vorheriger Schlusskurs	37.22

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

37.25 / 37.3 Unterstützung & Widerstand

USANA Health Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Nov. 2024, 22:50 UTC

Heiße Aktien

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1. Nov. 2024, 22:43 UTC

Wichtige Markttreiber

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1. Nov. 2024, 22:13 UTC

Wichtige Markttreiber

Chewy Up 5% on S&P MidCap 400 Inclusion

1. Nov. 2024, 21:39 UTC

Ergebnisse

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

2. Nov. 2024, 13:53 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2. Nov. 2024, 13:44 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 13:00 UTC

Ergebnisse

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2. Nov. 2024, 12:58 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:48 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2. Nov. 2024, 12:32 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:28 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. Nov. 2024, 12:17 UTC

Ergebnisse

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q EPS $18272.00 >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Net $26.25B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA

2. Nov. 2024, 12:00 UTC

Ergebnisse

Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA

2. Nov. 2024, 09:30 UTC

Peer-Vergleich

Kursveränderung

USANA Health Sciences Inc Prognose

Kursziel

By TipRanks

-6.14% Nachteil

12-Monats-Prognose

Durchschnitt 35 USD -6.14%

Hoch 35 USD

Tief 35 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für USANA Health Sciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für USANA Health Sciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

37.25 / 37.3Unterstützung & Widerstand

Bullish events outweigh bearish events.

There is one bullish event.

There are no events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über USANA Health Sciences Inc

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.